Transcatheter Treatment for Mitral Regurgitation
(CHOICE-MI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice.
Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy.
Who Is on the Research Team?
Lenard Conradi, MD
Principal Investigator
University of Cologne
Thomas Modine, MD
Principal Investigator
University Hospital, Bordeaux
Juan F Granada, MD
Principal Investigator
Cardiovascular Research Foundation, New York, USA
Sebastian Ludwig, MD
Principal Investigator
University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo transcatheter mitral valve replacement (TMVR) in real-world clinical practice
Follow-up
Participants are monitored for clinical outcomes and mitral insufficiency severity
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor
Montreal Heart Institute
Collaborator
University Hospital, Bordeaux
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.